Use of preoperative glucocorticoid to reduce risk of complications after esophagectomy for carcinoma of the esophagus: Meta-analysis;Metanálise sobre o uso de glicocorticóide pré-operatório para redução do risco de complicações após esofagectomia por carcinoma do esôfago

Revista da Associacao Medica Brasileira

Volumn 53, Issue 2, 2007, Pages 158-161

  Raimondi, Antônio Marcos ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Esophagectomy; Meta analysis; Methylprednisolone; Multiple organ failure; Review literature

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; META ANALYSIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RISK; RISK FACTOR;

ADULT; CONTROLLED CLINICAL TRIALS AS TOPIC; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; GLUCOCORTICOIDS; HUMANS; METHYLPREDNISOLONE; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK FACTORS;

EID: 34250664890     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Holte K, Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2002;195(5):694-712.
2. Takeda S, Ogawa R, Nakanishi K, Kim C, Miyashita M, Sasajima K, et al. The effect of preoperative high dose methylprednisolone in attenuating the metabolic response after oesophageal resection. Eur J Surg. 1997;163(7):511-7.
3. Takeda S, Kim, C, Ikezaki H, Ikzaki H, Nakanishi K, Sakamoto A, et al. Preoperative administration of methylprednisolone attenuates cytokine-induced respiratory failure after esophageal resection. J Nippon Med Sch. 2003;70(1):16-20.
4. Raimondi AM. Esofagite no coto esofágico em pacientes submetidos à esofagogastroplastia para tratamento do megaesôfago avançado: avaliação clínica e endoscópica a longo prazo. [dissertação]. São Paulo: Faculdade de Medicina da Universidade de São Paulo; 2001.
5. Cecconello I, Rocha JRM, Raimondi AM, Oliveira MA, Gama-Rodrigues JJ. Reflux esophagitis and ectopic columnar epithelium in the esophageal stump after cervical gastroplasty: a reappraisal based on 17 years follow-up [abstract]. Gut. 2001;49(Suppl 3)3028.
6. McCulloch P, Ward J, Tekkis PP, ASCOT group of surgeons, British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastrooesophageal cancer surgery: initial results of ASCOT muticentre prospective cohort study. BMJ. 2003;327(7425):1192-7.
7. Rentz J, Bull D, Harpole D, Bailey S, Neumayer L, Pappas T, et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg. 2003;125(5):1114-20.
8. Meduri GU, Tolley EA, Chrousos GP, Stentz F. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med. 2002;165(7):983-91.
9. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348(8):727-34.
10. Sayama J, Shineha R, Yokota K. The effectiveness of preoperative steroid therapy in preventing postoperative circulatory system complications in surgery of esophageal cancer. Nippon Kyobu Geka Gakkai Zasshi. 1995;43(5):652-5.
11. Matsutani T, Onda M, Sasajima K, Miyashita M. Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res.1998;79(2):158-63.
12. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236(2):184-90.
13. Kikuchi T, Kugimiya H. Clinical effects of steroid in the perioperative management of patients undergoing extensive esophagectomy. Masui. 2002;51(7):722-7.
14. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Sage university paper series on quantitative applications in the social sciences. Newbury Park: Sage; 1986.
15. Leandro G. Meta-analysis in medical research: the handbook for the understanding and practice of meta-analysis. Malden: Blackwell; 2005.
16. Pearson K. Report on certain enteric fever inoculation statistics. BMJ. 1904;3(6):1243-6.
17. Fisher RA. Statistical methods for research workers. London: Oliver and Boyd; 1932.
18. Pearson K. On a method of determining whether a sample of size n supposed to have been drawn from a parent population having a known probability integral has probably been drawn at random. Biometrika. 1933;25(3):379-410.
19. Glass G. Primary, secondary, and meta-analysis of research. Educ Res. 1976;5:3-8.
20. L'Abbé K, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107(2):224-33.
21. Chalmers TC. Problems induced by meta-analyses. Stat Med. 1991; 10(9):971-80.
22. Felson DT. Bias in meta-analytic research. J Clin Epidemiol. 1992;45(8):885-92.
23. Raimondi AM. Dicionário fundamental de bioestatística. São Paulo: A M Raimondi; 2003.
24. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
25. Clarke M, Oxman AD, editors. Cochrane reviewers' handbook 4.1.6. [updated January 2003]. In: The Cochrane Library. The Cochrane Collaboration. Oxford: Update Software; 2003.
26. Iversen GR. Bayesian statistical inference. Sage university paper series on quantitative applications in the social sciences. Newbury Park: Sage; 1984.
27. Review Manager (RevMan) [Computer program] Version 4.2.2 for Windows. Oxford: The Cochrane Collaboration; 2004. (CD-ROM)
28. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003:349(22):2117-27.
29. Stubbs SS. Corticosteroids and bioavailability. Transplant Proc. 1975;7(1):11-9.
30. Fisher LE, Ludwig EA, Wald JA, Sloan RR, Middleton E Jr, Jusko WJ. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther. 1992;51(6):677-88.
31. Greos LS, Vichyanond P, Bloedow DC, Irvin CG, Larsen GL, Szeffer SJ, et al. Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis. 1991;144(3 Pt 1):586-92.
32. Rivers EP, McIntyre L, Morro DC, Rivers KK. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ. 2005; 173(9):1054-65.